Results 271 to 280 of about 66,500 (291)

Sirtuins in mechanistic target of rapamycin complex 1 signaling

2021
J. Burillo, P. Marqués, B. Jiménez, C. González-Blanco, M. Benito, C. Guillén   +5 more
openaire   +1 more source

Mechanistic/Mammalian Target of Rapamycin Complex 1 Signaling Network

2021
openaire   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Nature Reviews Clinical Oncology, 2022
, Giedre Krenciute, Dimitrios L Wagner
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Loss of the mechanistic target of rapamycin complexes 1 (mTORC1) causes a lethal alpha-1 antitrypsin deficiency associated liver disease

Zeitschrift für Gastroenterologie, 2023
Lisa Bewersdorf, Yizhao Luo, Annika Schmitz, Christian Preisinger, Thorsten Cramer, Pavel Strnad   +5 more
openaire   +1 more source

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control

Ca-A Cancer Journal for Clinicians, 2019
Otis W Brawley, Ted Gansler, Robert A Smith   +2 more
exaly